Bailard, Inc. Catalent, Inc. Transaction History

Bailard, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$101.51 - $125.27 $686,207 - $846,825	-6,760 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$85.88 - $105.36 $205,424 - $252,021	-2,392 Reduced 26.14%	6,760 $704,000
Q2 2020 Aug 12, 2020	BUY	$48.02 - $79.04 $50,421 - $82,992	1,050 Added 12.96%	9,152 $671,000
Q4 2019 Jan 31, 2020	BUY	$47.06 - $56.64 $51,860 - $62,417	1,102 Added 15.74%	8,102 $456,000
Q2 2019 Jul 26, 2019	BUY	$39.26 - $54.21 $274,820 - $379,470	7,000 New	7,000 $379,000

511

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.